Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

3.710 +0.130 (+3.63%)
Streaming Delayed Price Updated: 1:08 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Achieve Life Sciences, Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
News headline image
Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
News headline image
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,... 
Via Benzinga
Why Achieve Life Sciences' Stock is Trading Lower Today ↗
Achieve Life Sciences (NASDAQ:ACHV) shares are tradin... 
Via Benzinga
News headline image
Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE /... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2021 ↗
Upgrades B of A Securities upgraded the previous rating for UGI Corp (NYSE:UGI) from Neutral to Buy. UGI earned $1.99 in the second quarter, compared to $1.56 in the year-... 
Via Benzinga
News headline image
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
News headline image
Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
News headline image
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
News headline image
Mid-Afternoon Market Update: Dycom Industries Drops Following Q1 Results; The Joint Corp Shares Slide ↗
Toward the end of trading Tuesday, the Dow traded down 0.09% to 34,362.49 while the NASDAQ fell 0.04% to 13,655.88. The S&P also fell, dropping 0.14% to 4,191.36. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
54 Biggest Movers From Yesterday ↗
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's... 
Via Benzinga
News headline image
Mid-Day Market Update: US Stocks Turn Lower; Provention Bio Shares Surge ↗
Midway through trading Tuesday, the Dow traded down 0.16% to 34,337.29 while the NASDAQ fell 0.16% to 13,638.63. The S&P also fell, dropping 0.20% to 4,188.77. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
42 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's... 
Via Benzinga
News headline image
Achieve Life Sciences Stock Plunges After Raising $20M Via Equity at 19% Discount ↗
Achieve Life Sciences Inc (NASDAQ: ACHV) has priced its underwritten public offering of 2.9 million at $7 per share, representing a discount of 19% from the last... 
Via Benzinga
News headline image
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
25 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers U.S. Well Services, Inc. (NASDAQ: USWS) rose 30.5% to $1.25 in pre-market trading after the company reported commitment to becoming all-electric hydraulic facturing... 
Via Benzinga
News headline image
7 Stocks Moving In Monday's After-Hours Session ↗
Gainers Scholar Rock (NASDAQ: SRRK) shares are trading higher after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers OptiNose (NASDAQ:OPTN) stock rose... 
Via Benzinga
News headline image
Achieve Life Sciences Announces Proposed Underwritten Public Offering
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 24, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
News headline image
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
News headline image
Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization... 
From Achieve Life Sciences, Inc.
Via AccessWire
News headline image
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / April 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
News headline image
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
Cytisinicline Up to Five Times More Likely to Result in Smoking Abstinence Compared to Placebo Phase 3 ORCA-2 Trial Currently Enrolling at 16 sites in United States SEATTLE, WA and VANCOUVER, BC /... 
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.